메뉴 건너뛰기




Volumn 28, Issue 10, 2014, Pages 1461-1467

Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial

Author keywords

cancer; curcumin; cytokine; inflammation; quality of life; randomized controlled trial

Indexed keywords

C REACTIVE PROTEIN; CALCITONIN GENE RELATED PEPTIDE; CURCUMIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

EID: 84908503753     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5149     Document Type: Article
Times cited : (191)

References (54)
  • 1
    • 84881342288 scopus 로고    scopus 로고
    • Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers
    • Aggarwal BB, Gupta SC, Sung B,. 2013. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol 169: 1672 - 1692.
    • (2013) Br J Pharmacol , vol.169 , pp. 1672-1692
    • Aggarwal, B.B.1    Gupta, S.C.2    Sung, B.3
  • 3
    • 67749122326 scopus 로고    scopus 로고
    • Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: The case of the antioxidant curcumin
    • Barry J, Fritz M, Brender JR, et al. 2009. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc 131: 4490 - 4498.
    • (2009) J Am Chem Soc , vol.131 , pp. 4490-4498
    • Barry, J.1    Fritz, M.2    Brender, J.R.3
  • 4
    • 79959605403 scopus 로고    scopus 로고
    • Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment
    • Basnet P, Skalko-Basnet N,. 2011. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16: 4567 - 4598.
    • (2011) Molecules , vol.16 , pp. 4567-4598
    • Basnet, P.1    Skalko-Basnet, N.2
  • 5
    • 77954160638 scopus 로고    scopus 로고
    • Phase i dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
    • Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. 2010. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 9: 8 - 14.
    • (2010) Cancer Biol Ther , vol.9 , pp. 8-14
    • Bayet-Robert, M.1    Kwiatkowski, F.2    Leheurteur, M.3
  • 6
    • 84895806693 scopus 로고    scopus 로고
    • A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment
    • Belcaro G, Hosoi M, Pellegrini L, et al. 2013. A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment. Phytother Res. DOI: 10.1002/ptr.5014.
    • (2013) Phytother Res
    • Belcaro, G.1    Hosoi, M.2    Pellegrini, L.3
  • 7
    • 0036070626 scopus 로고    scopus 로고
    • Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4
    • Bhardwaj RK, Glaeser H, Becquemont L, et al. 2002. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302: 645 - 650.
    • (2002) J Pharmacol Exp Ther , vol.302 , pp. 645-650
    • Bhardwaj, R.K.1    Glaeser, H.2    Becquemont, L.3
  • 9
    • 79955804832 scopus 로고    scopus 로고
    • Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
    • Carroll RE, Benya RV, Turgeon DK, et al. 2011. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 4: 354 - 364.
    • (2011) Cancer Prev Res (Phila) , vol.4 , pp. 354-364
    • Carroll, R.E.1    Benya, R.V.2    Turgeon, D.K.3
  • 10
    • 0037291286 scopus 로고    scopus 로고
    • Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa)
    • Chainani-Wu N,. 2003. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9: 161 - 168.
    • (2003) J Altern Complement Med , vol.9 , pp. 161-168
    • Chainani-Wu, N.1
  • 11
    • 34447563962 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus
    • Chainani-Wu N, Silverman S, Jr., Reingold A, et al. 2007. A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine 14: 437 - 446.
    • (2007) Phytomedicine , vol.14 , pp. 437-446
    • Chainani-Wu, N.1    Silverman, S.2    Reingold, A.3
  • 12
    • 0035174504 scopus 로고    scopus 로고
    • Phase i clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
    • Cheng AL, Hsu CH, Lin JK, et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895 - 2900.
    • (2001) Anticancer Res , vol.21 , pp. 2895-2900
    • Cheng, A.L.1    Hsu, C.H.2    Lin, J.K.3
  • 13
    • 33746353391 scopus 로고    scopus 로고
    • Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis
    • Cruz-Correa M, Shoskes DA, Sanchez P, et al. 2006. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4: 1035 - 1038.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 1035-1038
    • Cruz-Correa, M.1    Shoskes, D.A.2    Sanchez, P.3
  • 14
    • 79955411920 scopus 로고    scopus 로고
    • Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation
    • Cuomo J, Appendino G, Dern AS, et al. 2011. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 74: 664 - 669.
    • (2011) J Nat Prod , vol.74 , pp. 664-669
    • Cuomo, J.1    Appendino, G.2    Dern, A.S.3
  • 15
    • 51649118928 scopus 로고    scopus 로고
    • Phase II trial of curcumin in patients with advanced pancreatic cancer
    • Dhillon N, Aggarwal BB, Newman RA, et al. 2008. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491 - 4499.
    • (2008) Clin Cancer Res , vol.14 , pp. 4491-4499
    • Dhillon, N.1    Aggarwal, B.B.2    Newman, R.A.3
  • 16
    • 30744474181 scopus 로고    scopus 로고
    • A pilot study of the antioxidant effect of curcumin in tropical pancreatitis
    • Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S,. 2005. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 122: 315 - 318.
    • (2005) Indian J Med Res , vol.122 , pp. 315-318
    • Durgaprasad, S.1    Pai, C.G.2    Vasanthkumar, A.J.3    Namitha, S.4
  • 18
    • 78249286547 scopus 로고    scopus 로고
    • Curcumin and gemcitabine in patients with advanced pancreatic cancer
    • Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G,. 2010. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 62: 1137 - 1141.
    • (2010) Nutr Cancer , vol.62 , pp. 1137-1141
    • Epelbaum, R.1    Schaffer, M.2    Vizel, B.3    Badmaev, V.4    Bar-Sela, G.5
  • 19
    • 12844277237 scopus 로고    scopus 로고
    • Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences
    • Garcea G, Berry DP, Jones DJ, et al. 2005. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14: 120 - 125.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 120-125
    • Garcea, G.1    Berry, D.P.2    Jones, D.J.3
  • 20
    • 51349098155 scopus 로고    scopus 로고
    • Cytokines as a key component of cancer-related inflammation
    • Germano G, Allavena P, Mantovani A,. 2008. Cytokines as a key component of cancer-related inflammation. Cytokine 43: 374 - 379.
    • (2008) Cytokine , vol.43 , pp. 374-379
    • Germano, G.1    Allavena, P.2    Mantovani, A.3
  • 21
    • 70349466801 scopus 로고    scopus 로고
    • The potential role of curcumin in patients with monoclonal gammopathy of undefined significance-its effect on paraproteinemia and the urinary N-telopeptide of type i collagen bone turnover marker
    • Golombick T, Diamond TH, Badmaev V, Manoharan A, Ramakrishna R,. 2009. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance-its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res 15: 5917 - 5922.
    • (2009) Clin Cancer Res , vol.15 , pp. 5917-5922
    • Golombick, T.1    Diamond, T.H.2    Badmaev, V.3    Manoharan, A.4    Ramakrishna, R.5
  • 22
    • 84871971567 scopus 로고    scopus 로고
    • Therapeutic roles of curcumin: Lessons learned from clinical trials
    • Gupta SC, Patchva S, Aggarwal BB,. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15: 195 - 218.
    • (2013) AAPS J , vol.15 , pp. 195-218
    • Gupta, S.C.1    Patchva, S.2    Aggarwal, B.B.3
  • 23
    • 77958114117 scopus 로고    scopus 로고
    • Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: Antioxidant coupled with antiinflammatory
    • Hu R, Saw CL, Yu R, Kong AN,. 2010. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid Redox Signal 13: 1679 - 1698.
    • (2010) Antioxid Redox Signal , vol.13 , pp. 1679-1698
    • Hu, R.1    Saw, C.L.2    Yu, R.3    Kong, A.N.4
  • 24
    • 35648983903 scopus 로고    scopus 로고
    • Inflammation and cancer: An ancient link with novel potentials
    • Hussain SP, Harris CC,. 2007. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121: 2373 - 2380.
    • (2007) Int J Cancer , vol.121 , pp. 2373-2380
    • Hussain, S.P.1    Harris, C.C.2
  • 25
    • 77953425009 scopus 로고    scopus 로고
    • Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen
    • Ide H, Tokiwa S, Sakamaki K, et al. 2010. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate 70: 1127 - 1133.
    • (2010) Prostate , vol.70 , pp. 1127-1133
    • Ide, H.1    Tokiwa, S.2    Sakamaki, K.3
  • 26
    • 0033568674 scopus 로고    scopus 로고
    • Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity
    • Jobin C, Bradham CA, Russo MP, et al. 1999. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163: 3474 - 3483.
    • (1999) J Immunol , vol.163 , pp. 3474-3483
    • Jobin, C.1    Bradham, C.A.2    Russo, M.P.3
  • 27
    • 79959612772 scopus 로고    scopus 로고
    • A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
    • Kanai M, Yoshimura K, Asada M, et al. 2011. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 68: 157 - 164.
    • (2011) Cancer Chemother Pharmacol , vol.68 , pp. 157-164
    • Kanai, M.1    Yoshimura, K.2    Asada, M.3
  • 28
    • 33745298519 scopus 로고    scopus 로고
    • Nuclear factor-kappaB in cancer development and progression
    • Karin M,. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431 - 436.
    • (2006) Nature , vol.441 , pp. 431-436
    • Karin, M.1
  • 29
    • 80052832976 scopus 로고    scopus 로고
    • Curcumin treatment suppresses IKKbeta kinase activity of salivary cells of patients with head and neck cancer: A pilot study
    • Kim SG, Veena MS, Basak SK, et al. 2011. Curcumin treatment suppresses IKKbeta kinase activity of salivary cells of patients with head and neck cancer: a pilot study. Clin Cancer Res 17: 5953 - 5961.
    • (2011) Clin Cancer Res , vol.17 , pp. 5953-5961
    • Kim, S.G.1    Veena, M.S.2    Basak, S.K.3
  • 30
    • 79955585058 scopus 로고    scopus 로고
    • Cytokines, inflammation and colon cancer
    • Klampfer L,. 2011. Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 11: 451 - 464.
    • (2011) Curr Cancer Drug Targets , vol.11 , pp. 451-464
    • Klampfer, L.1
  • 31
    • 67649407501 scopus 로고    scopus 로고
    • Curcumin in clinical practice: Myth or reality?
    • Mancuso C, Barone E,. 2009. Curcumin in clinical practice: myth or reality? Trends Pharmacol Sci 30: 333 - 334.
    • (2009) Trends Pharmacol Sci , vol.30 , pp. 333-334
    • Mancuso, C.1    Barone, E.2
  • 32
    • 34248385769 scopus 로고    scopus 로고
    • Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
    • Marczylo TH, Verschoyle RD, Cooke DN, et al. 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60: 171 - 177.
    • (2007) Cancer Chemother Pharmacol , vol.60 , pp. 171-177
    • Marczylo, T.H.1    Verschoyle, R.D.2    Cooke, D.N.3
  • 33
    • 0035527477 scopus 로고    scopus 로고
    • Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer
    • McMillan DC, Elahi MM, Sattar N, et al. 2001. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41: 64 - 69.
    • (2001) Nutr Cancer , vol.41 , pp. 64-69
    • McMillan, D.C.1    Elahi, M.M.2    Sattar, N.3
  • 34
    • 33745224326 scopus 로고    scopus 로고
    • A feasibility study of computer-assisted health-related quality of life data collection in patients with oral and oropharyngeal cancer
    • Millsopp L, Frackleton S, Lowe D, Rogers SN,. 2006. A feasibility study of computer-assisted health-related quality of life data collection in patients with oral and oropharyngeal cancer. Int J Oral Maxillofac Surg 35: 761 - 764.
    • (2006) Int J Oral Maxillofac Surg , vol.35 , pp. 761-764
    • Millsopp, L.1    Frackleton, S.2    Lowe, D.3    Rogers, S.N.4
  • 35
    • 84874935664 scopus 로고    scopus 로고
    • Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial
    • Mohammadi A, Sahebkar A, Iranshahi M, et al. 2013. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res 27: 374 - 379.
    • (2013) Phytother Res , vol.27 , pp. 374-379
    • Mohammadi, A.1    Sahebkar, A.2    Iranshahi, M.3
  • 37
    • 43749098070 scopus 로고    scopus 로고
    • NF-kappaB and cancer-identifying targets and mechanisms
    • Naugler WE, Karin M,. 2008. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19 - 26.
    • (2008) Curr Opin Genet Dev , vol.18 , pp. 19-26
    • Naugler, W.E.1    Karin, M.2
  • 38
    • 84869485341 scopus 로고    scopus 로고
    • Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: Results of a randomised, double-blind, placebo-controlled trial
    • Panahi Y, Sahebkar A, Amiri M, et al. 2012a. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr 108: 1272 - 1279.
    • (2012) Br J Nutr , vol.108 , pp. 1272-1279
    • Panahi, Y.1    Sahebkar, A.2    Amiri, M.3
  • 39
    • 84872467113 scopus 로고    scopus 로고
    • A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications
    • Panahi Y, Sahebkar A, Parvin S, Saadat A,. 2012b. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem 49: 580 - 588.
    • (2012) Ann Clin Biochem , vol.49 , pp. 580-588
    • Panahi, Y.1    Sahebkar, A.2    Parvin, S.3    Saadat, A.4
  • 40
    • 79952496272 scopus 로고    scopus 로고
    • Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress
    • Rai B, Kaur J, Jacobs R, Singh J,. 2010. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci 52: 251 - 256.
    • (2010) J Oral Sci , vol.52 , pp. 251-256
    • Rai, B.1    Kaur, J.2    Jacobs, R.3    Singh, J.4
  • 41
    • 77957204556 scopus 로고    scopus 로고
    • Molecular mechanisms for curcumin benefits against ischemic injury
    • Sahebkar A,. 2010. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril 94: e75 - 76; author reply e77.
    • (2010) Fertil Steril , vol.94 , pp. 75-76
    • Sahebkar, A.1
  • 42
    • 84899477785 scopus 로고    scopus 로고
    • Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis
    • Sahebkar A,. 2013a. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. DOI: 10.1002/ptr.5045
    • (2013) Phytother Res
    • Sahebkar, A.1
  • 43
    • 84876439194 scopus 로고    scopus 로고
    • Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
    • Sahebkar A,. 2013b. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors 39: 197 - 208.
    • (2013) Biofactors , vol.39 , pp. 197-208
    • Sahebkar, A.1
  • 44
    • 84890552304 scopus 로고    scopus 로고
    • Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals
    • Sahebkar A, Mohammadi A, Atabati A, et al. 2013. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res 27 (12): 1883 - 1888.
    • (2013) Phytother Res , vol.27 , Issue.12 , pp. 1883-1888
    • Sahebkar, A.1    Mohammadi, A.2    Atabati, A.3
  • 45
    • 77954213464 scopus 로고    scopus 로고
    • Supramolecular phospholipids-polyphenolics interactions: The PHYTOSOME strategy to improve the bioavailability of phytochemicals
    • Semalty A, Semalty M, Rawat MS, Franceschi F,. 2010. Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. Fitoterapia 81: 306 - 314.
    • (2010) Fitoterapia , vol.81 , pp. 306-314
    • Semalty, A.1    Semalty, M.2    Rawat, M.S.3    Franceschi, F.4
  • 46
    • 33947373996 scopus 로고    scopus 로고
    • Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis
    • Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A,. 2007. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem Pharmacol 73: 1434 - 1445.
    • (2007) Biochem Pharmacol , vol.73 , pp. 1434-1445
    • Shakibaei, M.1    John, T.2    Schulze-Tanzil, G.3    Lehmann, I.4    Mobasheri, A.5
  • 47
    • 6044276740 scopus 로고    scopus 로고
    • Phase i clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
    • Sharma RA, Euden SA, Platton SL, et al. 2004. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10: 6847 - 6854.
    • (2004) Clin Cancer Res , vol.10 , pp. 6847-6854
    • Sharma, R.A.1    Euden, S.A.2    Platton, S.L.3
  • 48
    • 0034772953 scopus 로고    scopus 로고
    • Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer
    • Sharma RA, McLelland HR, Hill KA, et al. 2001. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7: 1894 - 1900.
    • (2001) Clin Cancer Res , vol.7 , pp. 1894-1900
    • Sharma, R.A.1    McLelland, H.R.2    Hill, K.A.3
  • 49
    • 84874114084 scopus 로고    scopus 로고
    • Curcumin in various cancers
    • Shehzad A, Lee J, Lee YS,. 2013. Curcumin in various cancers. Biofactors 39: 56 - 68.
    • (2013) Biofactors , vol.39 , pp. 56-68
    • Shehzad, A.1    Lee, J.2    Lee, Y.S.3
  • 50
    • 77956863976 scopus 로고    scopus 로고
    • Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials
    • Shehzad A, Wahid F, Lee YS,. 2010. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 343: 489 - 499.
    • (2010) Arch Pharm (Weinheim) , vol.343 , pp. 489-499
    • Shehzad, A.1    Wahid, F.2    Lee, Y.S.3
  • 51
    • 35948951161 scopus 로고    scopus 로고
    • Black pepper and its pungent principle-piperine: A review of diverse physiological effects
    • Srinivasan K,. 2007. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr 47: 735 - 748.
    • (2007) Crit Rev Food Sci Nutr , vol.47 , pp. 735-748
    • Srinivasan, K.1
  • 52
    • 38349011007 scopus 로고    scopus 로고
    • Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials
    • Strimpakos AS, Sharma RA,. 2008. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511 - 545.
    • (2008) Antioxid Redox Signal , vol.10 , pp. 511-545
    • Strimpakos, A.S.1    Sharma, R.A.2
  • 53
    • 46349109182 scopus 로고    scopus 로고
    • Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: A randomized, parallel-group, placebo-controlled, 8-week study
    • Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N,. 2008. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D 9: 243 - 250. Yamamoto Y and Gaynor RB. 2001. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107: 135-142.
    • (2008) Drugs R D , vol.9 , pp. 243-250
    • Usharani, P.1    Mateen, A.A.2    Naidu, M.U.3    Raju, Y.S.4    Chandra, N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.